JP6716199B2 - 真珠光沢の強膜を有するコンタクトレンズ - Google Patents
真珠光沢の強膜を有するコンタクトレンズ Download PDFInfo
- Publication number
- JP6716199B2 JP6716199B2 JP2015068219A JP2015068219A JP6716199B2 JP 6716199 B2 JP6716199 B2 JP 6716199B2 JP 2015068219 A JP2015068219 A JP 2015068219A JP 2015068219 A JP2015068219 A JP 2015068219A JP 6716199 B2 JP6716199 B2 JP 6716199B2
- Authority
- JP
- Japan
- Prior art keywords
- contact lens
- mica
- pearlescent
- pigment
- contact lenses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000003786 sclera Anatomy 0.000 title claims description 19
- 239000000049 pigment Substances 0.000 claims description 55
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 24
- 239000010445 mica Substances 0.000 claims description 17
- 229910052618 mica group Inorganic materials 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 16
- 239000000975 dye Substances 0.000 claims description 14
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000004408 titanium dioxide Substances 0.000 claims description 12
- 235000013968 mica-based pearlescent pigment Nutrition 0.000 claims description 11
- 210000001747 pupil Anatomy 0.000 claims description 8
- 239000002537 cosmetic Substances 0.000 description 43
- 239000003086 colorant Substances 0.000 description 19
- 238000000034 method Methods 0.000 description 18
- 230000008569 process Effects 0.000 description 17
- 230000002093 peripheral effect Effects 0.000 description 15
- 230000004438 eyesight Effects 0.000 description 12
- 239000000976 ink Substances 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 238000012937 correction Methods 0.000 description 11
- 230000000694 effects Effects 0.000 description 9
- 238000007639 printing Methods 0.000 description 9
- 239000000017 hydrogel Substances 0.000 description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
- 230000003287 optical effect Effects 0.000 description 7
- 239000001301 oxygen Substances 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 7
- 229920001296 polysiloxane Polymers 0.000 description 7
- NLAIHECABDOZBR-UHFFFAOYSA-M sodium 2,2-bis(2-methylprop-2-enoyloxymethyl)butyl 2-methylprop-2-enoate 2-hydroxyethyl 2-methylprop-2-enoate 2-methylprop-2-enoate Chemical compound [Na+].CC(=C)C([O-])=O.CC(=C)C(=O)OCCO.CCC(COC(=O)C(C)=C)(COC(=O)C(C)=C)COC(=O)C(C)=C NLAIHECABDOZBR-UHFFFAOYSA-M 0.000 description 7
- 230000008859 change Effects 0.000 description 6
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 6
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 5
- 210000004087 cornea Anatomy 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- KIWATKANDHUUOB-UHFFFAOYSA-N propan-2-yl 2-hydroxypropanoate Chemical compound CC(C)OC(=O)C(C)O KIWATKANDHUUOB-UHFFFAOYSA-N 0.000 description 5
- 229910052709 silver Inorganic materials 0.000 description 5
- 239000004332 silver Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 201000009310 astigmatism Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000001023 inorganic pigment Substances 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 239000012860 organic pigment Substances 0.000 description 4
- 230000035699 permeability Effects 0.000 description 4
- AVTLBBWTUPQRAY-UHFFFAOYSA-N 2-(2-cyanobutan-2-yldiazenyl)-2-methylbutanenitrile Chemical compound CCC(C)(C#N)N=NC(C)(CC)C#N AVTLBBWTUPQRAY-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 3
- 229910010413 TiO 2 Inorganic materials 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- WNAHIZMDSQCWRP-UHFFFAOYSA-N dodecane-1-thiol Chemical compound CCCCCCCCCCCCS WNAHIZMDSQCWRP-UHFFFAOYSA-N 0.000 description 3
- 201000006318 hyperopia Diseases 0.000 description 3
- 230000004305 hyperopia Effects 0.000 description 3
- 208000016339 iris pattern Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 208000001491 myopia Diseases 0.000 description 3
- 230000004379 myopia Effects 0.000 description 3
- 238000007649 pad printing Methods 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 2
- IHDBZCJYSHDCKF-UHFFFAOYSA-N 4,6-dichlorotriazine Chemical compound ClC1=CC(Cl)=NN=N1 IHDBZCJYSHDCKF-UHFFFAOYSA-N 0.000 description 2
- 102100040409 Ameloblastin Human genes 0.000 description 2
- 101000891247 Homo sapiens Ameloblastin Proteins 0.000 description 2
- 206010020675 Hypermetropia Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- SXQXMCWCWVCFPC-UHFFFAOYSA-N aluminum;potassium;dioxido(oxo)silane Chemical group [Al+3].[K+].[O-][Si]([O-])=O.[O-][Si]([O-])=O SXQXMCWCWVCFPC-UHFFFAOYSA-N 0.000 description 2
- 229940067573 brown iron oxide Drugs 0.000 description 2
- 210000000795 conjunctiva Anatomy 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 2
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 125000001475 halogen functional group Chemical group 0.000 description 2
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 2
- LDHBWEYLDHLIBQ-UHFFFAOYSA-M iron(3+);oxygen(2-);hydroxide;hydrate Chemical compound O.[OH-].[O-2].[Fe+3] LDHBWEYLDHLIBQ-UHFFFAOYSA-M 0.000 description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 201000010041 presbyopia Diseases 0.000 description 2
- 208000014733 refractive error Diseases 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 1
- CGLVZFOCZLHKOH-UHFFFAOYSA-N 8,18-dichloro-5,15-diethyl-5,15-dihydrodiindolo(3,2-b:3',2'-m)triphenodioxazine Chemical compound CCN1C2=CC=CC=C2C2=C1C=C1OC3=C(Cl)C4=NC(C=C5C6=CC=CC=C6N(C5=C5)CC)=C5OC4=C(Cl)C3=NC1=C2 CGLVZFOCZLHKOH-UHFFFAOYSA-N 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 208000030374 Pupillary disease Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 208000008303 aniridia Diseases 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- XCJYREBRNVKWGJ-UHFFFAOYSA-N copper(II) phthalocyanine Chemical compound [Cu+2].C12=CC=CC=C2C(N=C2[N-]C(C3=CC=CC=C32)=N2)=NC1=NC([C]1C=CC=CC1=1)=NC=1N=C1[C]3C=CC=CC3=C2[N-]1 XCJYREBRNVKWGJ-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000000059 patterning Methods 0.000 description 1
- -1 phthalocyanime Chemical compound 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001179 pupillary effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/02—Lenses; Lens systems ; Methods of designing lenses
- G02C7/04—Contact lenses for the eyes
- G02C7/049—Contact lenses having special fitting or structural features achieved by special materials or material structures
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/02—Lenses; Lens systems ; Methods of designing lenses
- G02C7/04—Contact lenses for the eyes
- G02C7/046—Contact lenses having an iris pattern
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Eyeglasses (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pigments, Carbon Blacks, Or Wood Stains (AREA)
- Paints Or Removers (AREA)
Description
(1) コンタクトレンズであって、
眼の強膜部に実質的に対応する第1の領域と、
眼の非強膜部に実質的に対応する第2の領域と、
該第1の領域に含有され、光沢があり、光輝き、かつ真珠光沢がある外観を有する強膜領域を生成するように構成された、マイカ系真珠光沢顔料と、を含む、コンタクトレンズ。
(2) 前記マイカ系真珠光沢顔料は、酸化物層でコーティングされている、実施態様1に記載のコンタクトレンズ。
(3) 前記酸化物層は、二酸化チタンを含む、実施態様2に記載のコンタクトレンズ。
(4) 前記酸化物層は、酸化鉄を含む、実施態様2に記載のコンタクトレンズ。
(5) 前記マイカ系真珠光沢顔料は、珪酸アルミニウムカリウム(potassium aluminum silicate)を含む、実施態様1に記載のコンタクトレンズ。
(7) 前記マイカ系真珠光沢顔料は、非ランダムなパターンで配置される、実施態様1に記載のコンタクトレンズ。
(8) 前記マイカ系真珠光沢顔料は、前記第1の領域に包含される、実施態様1に記載のコンタクトレンズ。
(9) 前記マイカ系真珠光沢顔料と組み合わせられる1つ又は2つ以上の非マイカ系真珠光沢顔料を更に含む、実施態様1に記載のコンタクトレンズ。
(10) 前記マイカ系真珠光沢顔料と組み合わせられる1つ又は2つ以上の非真珠光沢顔料を更に含む、実施態様1に記載のコンタクトレンズ。
Claims (9)
- 自然に見える、より明るい白色の強膜領域を提供するための、コンタクトレンズであって、
前記コンタクトレンズの中心部にあり、装着者の瞳孔を覆うように設計された、クリアな瞳孔領域と、
前記装着者の眼の強膜部に対応し、前記強膜部を覆うように設計された、第1の領域と、ここで前記第1の領域は組み込まれた明るい色を含み、
前記装着者の前記眼の虹彩部に対応し、前記虹彩部を覆うように設計された、第2の領域と、ここで前記第2の領域は前記第1の領域に内側にあり、前記クリアな瞳孔領域を包囲する、環状形を有し、
前記装着者の眼の前記強膜部を覆う該第1の領域に含有され、光沢があり、光輝き、かつ真珠光沢がある外観を有する前記強膜領域を生成するように構成された、マイカ系真珠光沢顔料と、を含み、
前記マイカ系真珠光沢顔料は、二酸化チタンコーティングされたマイカ系顔料を含み、
前記マイカ系真珠光沢顔料は、前記コンタクトレンズの前記第1の領域のみに含有され、
前記マイカ系真珠光沢顔料は、前記コンタクトレンズを形成する材料内に封入されている、コンタクトレンズ。 - 前記マイカ系真珠光沢顔料は前記コンタクトレンズを形成する材料内に封入されたものである、請求項1に記載のコンタクトレンズ。
- 前記二酸化チタンコーティングされたマイカ系顔料は、銀タイプのマイカ系顔料である、請求項1に記載のコンタクトレンズ。
- 前記マイカ系真珠光沢顔料は、酸化鉄を更に含む、請求項1に記載のコンタクトレンズ。
- 前記マイカ系真珠光沢顔料は、ランダムなパターンで配置される、請求項1に記載のコンタクトレンズ。
- 前記マイカ系真珠光沢顔料は、非ランダムなパターンで配置される、請求項1に記載のコンタクトレンズ。
- 前記マイカ系真珠光沢顔料と組み合わせられる1種又は2種以上の非マイカ系真珠光沢顔料を更に含む、請求項1に記載のコンタクトレンズ。
- 前記マイカ系真珠光沢顔料と組み合わせられる1種又は2種以上の非真珠光沢顔料を更に含む、請求項1に記載のコンタクトレンズ。
- 前記マイカ系真珠光沢顔料と組み合わせられる1種又は2種以上の染料を更に含む、請求項1に記載のコンタクトレンズ。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/230,556 US9664927B2 (en) | 2014-03-31 | 2014-03-31 | Contact lens with pearlescent sclera |
US14/230,556 | 2014-03-31 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020039717A Division JP2020109525A (ja) | 2014-03-31 | 2020-03-09 | 真珠光沢の強膜を有するコンタクトレンズ |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015197679A JP2015197679A (ja) | 2015-11-09 |
JP6716199B2 true JP6716199B2 (ja) | 2020-07-01 |
Family
ID=52875505
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015068219A Active JP6716199B2 (ja) | 2014-03-31 | 2015-03-30 | 真珠光沢の強膜を有するコンタクトレンズ |
JP2020039717A Pending JP2020109525A (ja) | 2014-03-31 | 2020-03-09 | 真珠光沢の強膜を有するコンタクトレンズ |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020039717A Pending JP2020109525A (ja) | 2014-03-31 | 2020-03-09 | 真珠光沢の強膜を有するコンタクトレンズ |
Country Status (12)
Country | Link |
---|---|
US (1) | US9664927B2 (ja) |
EP (1) | EP2927734A1 (ja) |
JP (2) | JP6716199B2 (ja) |
KR (1) | KR102363994B1 (ja) |
CN (1) | CN104950472A (ja) |
AU (1) | AU2015201373B2 (ja) |
BR (1) | BR102015007194A2 (ja) |
CA (1) | CA2886382A1 (ja) |
HK (1) | HK1215074A1 (ja) |
RU (1) | RU2611930C2 (ja) |
SG (1) | SG10201502114WA (ja) |
TW (1) | TWI639041B (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9798162B2 (en) * | 2015-03-11 | 2017-10-24 | Johnson & Johnson Vision Care, Inc. | Annular shaped clear layer in cosmetic contact lenses |
US20170276959A1 (en) * | 2016-03-22 | 2017-09-28 | Johnson & Johnson Vision Care, Inc. | Contact lens with improved, multiple and integrated effects |
US20180092776A1 (en) | 2016-09-30 | 2018-04-05 | Sara Heikali | Method and device for treating and managing diseased ocular tissue |
CN117555164A (zh) * | 2017-06-14 | 2024-02-13 | 株式会社目立康 | 美容用隐形眼镜 |
KR101949147B1 (ko) | 2017-11-10 | 2019-05-20 | 주식회사 인터로조 | 오팔광택 콘택트렌즈 및 이의 제조방법 |
KR102103696B1 (ko) * | 2018-11-20 | 2020-04-23 | 주식회사 아이코디 | 컬러 콘택트렌즈 |
JP1725301S (ja) * | 2021-02-19 | 2022-09-21 | コンタクトレンズ | |
EP4330763A1 (en) * | 2021-04-29 | 2024-03-06 | Alcon Inc. | Colored cosmetic photochromic contact lenses |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4495313A (en) | 1981-04-30 | 1985-01-22 | Mia Lens Production A/S | Preparation of hydrogel for soft contact lens with water displaceable boric acid ester |
US4652099A (en) * | 1984-05-30 | 1987-03-24 | Lichtman William M | Scleral ring |
US4680336A (en) | 1984-11-21 | 1987-07-14 | Vistakon, Inc. | Method of forming shaped hydrogel articles |
US20030030773A1 (en) * | 1998-03-12 | 2003-02-13 | Ocampo Gerardo J. | Colored contact lens with a more natural appearance |
US6165260A (en) | 1999-03-30 | 2000-12-26 | Engelhard Corporation | Pearlescent pigments exhibiting color travel |
US6196683B1 (en) * | 1999-04-23 | 2001-03-06 | Wesley Jessen Corporation | Pearlescent contact lens |
US7267846B2 (en) * | 1999-11-01 | 2007-09-11 | Praful Doshi | Tinted lenses and methods of manufacture |
US6634747B1 (en) | 2000-06-07 | 2003-10-21 | Novartis Ag | Sample indicator lens |
US6811259B2 (en) | 2000-06-12 | 2004-11-02 | Novartis Ag | Printing colored contact lenses |
US20040150787A1 (en) | 2000-10-13 | 2004-08-05 | Niculas Corneliu Daniel | Contact lens with encapsulated light-reflective particles |
US6811805B2 (en) | 2001-05-30 | 2004-11-02 | Novatis Ag | Method for applying a coating |
US20030085934A1 (en) | 2001-11-07 | 2003-05-08 | Tucker Robert Carey | Ink-jet printing system for printing colored images on contact lenses |
GB0220312D0 (en) * | 2002-08-31 | 2002-10-09 | Graham Neil | Novel thermoplastic hydrogel polymer compositions for use in producing contact lenses and methods of producing said compositions |
US20120097194A1 (en) | 2002-09-09 | 2012-04-26 | Reactive Surfaces, Ltd. | Polymeric Coatings Incorporating Bioactive Enzymes for Catalytic Function |
US20110240064A1 (en) | 2002-09-09 | 2011-10-06 | Reactive Surfaces, Ltd. | Polymeric Coatings Incorporating Bioactive Enzymes for Cleaning a Surface |
US20100210745A1 (en) * | 2002-09-09 | 2010-08-19 | Reactive Surfaces, Ltd. | Molecular Healing of Polymeric Materials, Coatings, Plastics, Elastomers, Composites, Laminates, Adhesives, and Sealants by Active Enzymes |
US20110250626A1 (en) | 2002-09-09 | 2011-10-13 | Reactive Surfaces, Ltd. | Visual Assays for Coatings Incorporating Bioactive Enzymes for Catalytic Functions |
JP2006523735A (ja) | 2003-04-18 | 2006-10-19 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | 抗菌顔料 |
DE10322841A1 (de) | 2003-05-19 | 2004-12-16 | Merck Patent Gmbh | Duales Sicherheitsmerkmal |
US7278736B2 (en) | 2004-02-25 | 2007-10-09 | Novartis Ag | Contact lenses imparting a vivacious appearance to the eye |
US8147728B2 (en) | 2004-04-01 | 2012-04-03 | Novartis Ag | Pad transfer printing of silicone hydrogel lenses using colored ink |
ES2498971T3 (es) | 2004-04-21 | 2014-09-26 | Novartis Ag | Tintas coloreadas curables para fabricar lentes de hidrogel de silicona coloreados |
EP1774368B1 (en) | 2004-07-28 | 2009-08-26 | Novartis AG | Water-based inks for hydrogel lenses |
US7246903B2 (en) * | 2004-08-19 | 2007-07-24 | Johnson & Johnson Vision Care, Inc. | Tinted contact lenses with combined limbal ring and iris patterns |
US20060244908A1 (en) | 2004-08-30 | 2006-11-02 | Glucose Sensing Technologies, Llc | Colored contact lens |
TW200613391A (en) | 2004-09-01 | 2006-05-01 | Novartis Ag | Method for making colored silicone hydrogel contact lenses |
US20060115440A1 (en) * | 2004-09-07 | 2006-06-01 | Arata Andrew B | Silver dihydrogen citrate compositions |
US20060065138A1 (en) | 2004-09-30 | 2006-03-30 | Tucker Robert C | Pad printing method for making colored contact lenses |
US20070244211A1 (en) | 2004-11-22 | 2007-10-18 | Phelan John C | Crosslinkable poly(oxyalkylene)-containing polyamide prepolymers |
WO2006063836A1 (en) | 2004-12-17 | 2006-06-22 | Novartis Ag | Colored contact lenses for enhancing a wearer’s natural eye color |
FR2886841B1 (fr) | 2005-06-10 | 2007-07-20 | Oreal | Produit cosmetique comprenant deux compositions distinctes dont l'une contient un polyrotaxane reticule. |
FR2886840B1 (fr) | 2005-06-10 | 2007-07-20 | Oreal | Composition cosmetique anhydre contenant un polyrotaxane reticule et une huile |
DE102005057593A1 (de) | 2005-07-08 | 2007-01-11 | Schwan-Stabilo Cosmetics Gmbh & Co. Kg | Zubereitung, insbesondere kosmetische Zubereitung, sowie ihre Herstellung und Verwendung |
DE102005033520B4 (de) | 2005-07-14 | 2007-12-20 | Schwan-Stabilo Cosmetics Gmbh & Co. Kg | Zubereitung, insbesondere kosmetische Zubereitung, Verfahren zu ihrer Herstellung und ihre Verwendung |
US20070296917A1 (en) * | 2006-06-23 | 2007-12-27 | Bowers Jackie W | Tinted contact lenses having iris patterns with enhanced depth |
FR2904534B1 (fr) | 2006-08-04 | 2008-09-19 | Oreal | Procede de maquillage ou de soin des matieres keratiniques avec polyrotaxanes non reticule |
US20080207774A1 (en) | 2006-08-24 | 2008-08-28 | Venkataram Krishnan | Anionic latex as a carrier for active ingredients and methods for making and using the same |
US20080233062A1 (en) | 2006-08-24 | 2008-09-25 | Venkataram Krishnan | Cationic latex as a carrier for active ingredients and methods for making and using the same |
JP5669396B2 (ja) * | 2006-12-13 | 2015-02-12 | ノバルティス アーゲー | 化学線硬化性シリコーンヒドロゲルコポリマーおよびその使用 |
US20100119461A1 (en) | 2007-01-23 | 2010-05-13 | Merck Patent Gmbh | Antimicrobial composition |
KR101662339B1 (ko) | 2008-09-02 | 2016-10-04 | 바스프 에스이 | 레올로지 개질제로서 유용한 공중합체 및 가정 및 개인 관리 조성물 |
WO2011084442A1 (en) | 2009-12-17 | 2011-07-14 | Novartis Ag | Pad transfer printing method for making colored contact lenses |
US8317322B2 (en) | 2010-02-04 | 2012-11-27 | Johnson & Johnson Vision Care, Inc. | Contact lens with brightly colored sclera |
US20110301247A1 (en) | 2010-06-08 | 2011-12-08 | Hayakawa Chihiro | Cosmetic product containing film-forming polymer |
KR101938900B1 (ko) * | 2010-07-29 | 2019-01-15 | 노파르티스 아게 | 컬러 콘택트 렌즈 및 그의 제조 방법 |
KR20180096806A (ko) * | 2010-12-14 | 2018-08-29 | 노파르티스 아게 | 컬러 콘택트 렌즈 |
BR112013026832A2 (pt) * | 2011-04-18 | 2016-12-27 | Johnson & Johnson Vision Care | lente de contato com esclera em cor viva |
US9104042B2 (en) | 2011-11-02 | 2015-08-11 | Johnson & Johnson Vision Care, Inc. | Oriented contact lens with brightly colored sclera |
US9205608B2 (en) | 2011-12-31 | 2015-12-08 | Novartis Ag | Contact lenses with identifying mark |
CN104023958B (zh) | 2011-12-31 | 2017-03-01 | 诺华股份有限公司 | 有色接触透镜的制备方法 |
US20130272995A1 (en) | 2012-04-12 | 2013-10-17 | Mamoru Hagiwara | Cosmetic product containing film-forming polymer |
US8721073B2 (en) * | 2012-07-16 | 2014-05-13 | Johnson & Johnson Vision Care, Inc. | Ophthalmic lens with repeating wave patterns |
US9072678B2 (en) | 2013-03-14 | 2015-07-07 | Pathak Holdings Llc | Methods for local drug delivery by microinjection |
-
2014
- 2014-03-31 US US14/230,556 patent/US9664927B2/en active Active
-
2015
- 2015-03-16 AU AU2015201373A patent/AU2015201373B2/en not_active Ceased
- 2015-03-18 SG SG10201502114WA patent/SG10201502114WA/en unknown
- 2015-03-26 CA CA2886382A patent/CA2886382A1/en not_active Abandoned
- 2015-03-27 TW TW104109893A patent/TWI639041B/zh active
- 2015-03-30 EP EP15161586.1A patent/EP2927734A1/en not_active Withdrawn
- 2015-03-30 KR KR1020150044178A patent/KR102363994B1/ko active IP Right Grant
- 2015-03-30 RU RU2015111510A patent/RU2611930C2/ru active
- 2015-03-30 JP JP2015068219A patent/JP6716199B2/ja active Active
- 2015-03-31 CN CN201510147858.5A patent/CN104950472A/zh active Pending
- 2015-03-31 BR BR102015007194A patent/BR102015007194A2/pt not_active Application Discontinuation
-
2016
- 2016-03-15 HK HK16102959.7A patent/HK1215074A1/zh unknown
-
2020
- 2020-03-09 JP JP2020039717A patent/JP2020109525A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2015201373B2 (en) | 2019-07-04 |
KR20150113899A (ko) | 2015-10-08 |
TWI639041B (zh) | 2018-10-21 |
CN104950472A (zh) | 2015-09-30 |
US20150277148A1 (en) | 2015-10-01 |
SG10201502114WA (en) | 2015-10-29 |
TW201546518A (zh) | 2015-12-16 |
KR102363994B1 (ko) | 2022-02-18 |
JP2020109525A (ja) | 2020-07-16 |
US9664927B2 (en) | 2017-05-30 |
RU2611930C2 (ru) | 2017-03-01 |
JP2015197679A (ja) | 2015-11-09 |
CA2886382A1 (en) | 2015-09-30 |
BR102015007194A2 (pt) | 2015-12-15 |
HK1215074A1 (zh) | 2016-08-12 |
EP2927734A1 (en) | 2015-10-07 |
RU2015111510A (ru) | 2016-10-20 |
AU2015201373A1 (en) | 2015-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7282859B2 (ja) | 改善された複数の統合的効果を伴うコンタクトレンズ | |
JP6716199B2 (ja) | 真珠光沢の強膜を有するコンタクトレンズ | |
JP6797536B2 (ja) | 美容用コンタクトレンズ内の環形状クリア層 | |
US9715129B2 (en) | Contact lens with multi-layered pattern | |
KR20230162526A (ko) | 개선된 미용을 갖는 콘택트 렌즈 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180117 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20180913 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180925 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20181213 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190521 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190821 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20200107 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200309 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20200316 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200602 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200610 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6716199 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |